The Federal Trade Commission (FTC) fined the developers of two mobile apps, MelApp and Mole Detective, both of which were previously available on Google Play and the App store as paid apps, for misleading consumers by falsely claiming to detect symptoms of melanoma.
 
The Director of the FTC’s Bureau of Consumer Protection stressed that "truth in advertising laws applies in the mobile marketplace… app developers and marketers must have scientific evidence to support any health or disease claims that they make for their apps.”
 
This development demonstrates the growing scrutiny which mobile app developers face from governmental agencies, in particular with respect to health care apps.